Medium Sized Enterprises / Research Directors Group / EFPIA Research Directors Group / Public-Private Partnership / reducing the time-to-fund SMEs / /
Continent
Europe / /
Currency
EUR / /
IndustryTerm
treatment of human diseases / candidate products / biotechnology / pharmaceutical sectors / public health insurance sectors / large pharmaceutical / online public consultations / health technology assessment authorities / pro-active communications / patent law / pharmaceutical / online public consultation / healthcare providers / /
Organization
IMI2 Board / IMI Office / IMI IP / IM IP / European Commission / European Federation of Pharmaceutical Industries and Associations / European Union / European Commission EFPIA European Federation of Pharmaceutical Industries and Associations EoI Expression / IMI JU / IMI2 / IMI PPP / /
Position
broker / Medium Seized Enterprise SRA Strategic Research Agenda Executive / Executive Office / Private / /
Product
Horizon / /
ProgrammingLanguage
EC / /
ProvinceOrState
Member / /
PublishedMedium
the PPP A review / /
Technology
drug discovery / biotechnology / 2020 IP Intellectual Property IPR Intellectual Property Rights JTI Joint Technology / drug development / /
Report of the Independent Expert Panel Accompanying the Commission report Assessment of European Innovative Medicines Initiative 2 A Joint Technology Initiative Under Horizon 2020